---
figid: PMC7395702__CMAR-12-6493-g0001
figtitle: Signal Transduction Pathway of PD-1 / PD-L1
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7395702
filename: CMAR-12-6493-g0001.jpg
figlink: pmc/articles/PMC7395702/figure/f0001/
number: F1
caption: The Signal Transduction Pathway of PD-1 / PD-L1. Under normal circumstances,
  MHC molecules on the surface of tumor cells present tumor-related antigens to TCR
  of T cells, which stimulates T cells to proliferate and differentiate into tumor-specific
  killer T cells through a series of downstream signaling pathways. But in the tumor
  microenvironment the combination of PD-1 expressed on T cells with its ligand PD-L1
  expressed on tumor cells can inhibit the downstream signaling pathway of TCR, leading
  to T cell disability and tumor immune escape.
papertitle: 'A Review About Pembrolizumab in First-Line Treatment of Advanced NSCLC:
  Focus on KEYNOTE Studies.'
reftext: Jialin Qu, et al. Cancer Manag Res. 2020;12:6493-6509.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6955434
figid_alias: PMC7395702__F1
figtype: Figure
redirect_from: /figures/PMC7395702__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7395702__CMAR-12-6493-g0001.html
  '@type': Dataset
  description: The Signal Transduction Pathway of PD-1 / PD-L1. Under normal circumstances,
    MHC molecules on the surface of tumor cells present tumor-related antigens to
    TCR of T cells, which stimulates T cells to proliferate and differentiate into
    tumor-specific killer T cells through a series of downstream signaling pathways.
    But in the tumor microenvironment the combination of PD-1 expressed on T cells
    with its ligand PD-L1 expressed on tumor cells can inhibit the downstream signaling
    pathway of TCR, leading to T cell disability and tumor immune escape.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFAT
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - AP-1gamma
  - Jra
  - kay
  - drk
  - Mhc
  - zip
  - et
  - Orc3
  - Tcr
  - Sos
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Erk7
  - rl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dsor1
  - Mtk
  - Akt
  - Mtor
  - Tor
  - Cdk4
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - CD274
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD247
  - CD3D
  - CD3E
  - CD3G
  - GRB2
  - HLA-C
  - LAT
  - ORC3
  - SPNS1
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - EPHB2
  - MAPK1
  - MAPK3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - TCR
  - AT
  - tumor
---
